Literature DB >> 26895546

Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis.

S Yoshino1, N Mizutani1.   

Abstract

BACKGROUND AND
PURPOSE: Fab fragments (Fabs) of antibodies have the ability to bind to specific allergens but lack the Fc portion that exerts effector functions via binding to receptors including FcεR1 on mast cells. In the present study, we investigated whether intranasal administration of the effector function-lacking Fabs of a monoclonal antibody IgG1 (mAb, P1-8) to the major allergen Cry j1 of Japanese cedar pollen (JCP) suppressed JCP-induced allergic rhinitis in mice. EXPERIMENTAL APPROACH: Balb/c mice sensitized with JCP on days 0 and 14 were challenged intranasally with the pollen on days 28, 29, 30 and 35. Fabs prepared by the digestion of P1-8 with papain were also administered intranasally 15 min before each JCP challenge. KEY
RESULTS: Intranasal administration of P1-8 Fabs was followed by marked suppression of sneezing and nasal rubbing in mice with JCP-induced allergic rhinitis. The suppression of these allergic symptoms by P1-8 Fabs was associated with decreases in mast cells and eosinophils and decreased hyperplasia of goblet cells in the nasal mucosa. CONCLUSIONS AND IMPLICATIONS: These results demonstrated that intranasal exposure to P1-8 Fabs was effective in suppressing JCP-induced allergic rhinitis in mice, suggesting that allergen-specific mAb Fabs might be used as a tool to regulate allergic pollinosis.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26895546      PMCID: PMC4842921          DOI: 10.1111/bph.13463

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  56 in total

1.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 2.  Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis.

Authors:  D P Skoner
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

3.  Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis.

Authors:  S Yoshino; N Mizutani
Journal:  Br J Pharmacol       Date:  2016-04-06       Impact factor: 8.739

Review 4.  Anti-IgE therapy: clinical utility and mechanistic insights.

Authors:  Stephanie L Logsdon; Hans C Oettgen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

5.  Antigen-induced arthritis in rats is suppressed by the inducing antigen administered orally before, but not after immunization.

Authors:  S Yoshino
Journal:  Cell Immunol       Date:  1995-06       Impact factor: 4.868

6.  Non-interventional study comparing treatment satisfaction in patients treated with antihistamines.

Authors:  Christine De Vos; Krassimir Mitchev; Marie-Etienne Pinelli; Marie-Paule Derde; Rossen Boev
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 7.  Chapter 15: Allergic rhinitis.

Authors:  Russell A Settipane; Christina Schwindt
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

8.  Preventive and therapeutic effects of rapamycin, a mammalian target of rapamycin inhibitor, on food allergy in mice.

Authors:  K Yamaki; S Yoshino
Journal:  Allergy       Date:  2012-08-23       Impact factor: 13.146

Review 9.  Omalizumab for severe asthma: efficacy beyond the atopic patient?

Authors:  Christian Domingo
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  2 in total

1.  Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis.

Authors:  S Yoshino; N Mizutani
Journal:  Br J Pharmacol       Date:  2016-04-06       Impact factor: 8.739

2.  Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis.

Authors:  Takashi Fujimura; Ayane Hori; Hideto Torii; Shinsuke Kishida; Yoshinori Matsuura; Seiji Kawamoto
Journal:  World Allergy Organ J       Date:  2018-12-04       Impact factor: 4.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.